PTEN and neoplasm: After five weeks, the main effect is to ameliorate PTEN null-mediated gene expression, so that SF itself acted as a surrogate PTEN tumour suppressor, although its effects were not sufficient in this model to reverse the histopathological changes induced by the knock out of PTEN in all prostate epithelial cells.